L Patrick Gage - Net Worth and Insider Trading
L Patrick Gage Net Worth
The estimated net worth of L Patrick Gage is at least $2 Million dollars as of 2024-11-13. L Patrick Gage is the Director of Cytokinetics Inc and owns about 30,782 shares of Cytokinetics Inc (CYTK) stock worth over $2 Million. L Patrick Gage is the Director of PDL BioPharma Inc and owns about 7,555 shares of PDL BioPharma Inc (PDLI) stock worth over $18,661. L Patrick Gage is also the Director of Tetraphase Pharmaceuticals Inc and owns about 1,944 shares of Tetraphase Pharmaceuticals Inc (TTPH) stock worth over $4,277. Details can be seen in L Patrick Gage's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that L Patrick Gage has not made any transactions after 2021-11-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of L Patrick Gage
L Patrick Gage Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, L Patrick Gage owns 3 companies in total, including Tetraphase Pharmaceuticals Inc (TTPH) , Cytokinetics Inc (CYTK) , and PDL BioPharma Inc (PDLI) .
Click here to see the complete history of L Patrick Gage’s form 4 insider trades.
Insider Ownership Summary of L Patrick Gage
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TTPH | Tetraphase Pharmaceuticals Inc | 2020-07-28 | director |
| CYTK | Cytokinetics Inc | 2021-11-08 | director |
| PDLI | PDL BioPharma Inc | 2008-04-28 | director & Interim CEO |
L Patrick Gage Latest Holdings Summary
L Patrick Gage currently owns a total of 3 stocks. Among these stocks, L Patrick Gage owns 30,782 shares of Cytokinetics Inc (CYTK) as of November 8, 2021, with a value of $2 Million and a weighting of 98.69%. L Patrick Gage owns 7,555 shares of PDL BioPharma Inc (PDLI) as of May 5, 2005, with a value of $18,661 and a weighting of 1.06%. L Patrick Gage also owns 1,944 shares of Tetraphase Pharmaceuticals Inc (TTPH) as of November 29, 2017, with a value of $4,277 and a weighting of 0.24%.
Latest Holdings of L Patrick Gage
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2021-11-08 | 30,782 | 56.21 | 1,730,102 |
| PDLI | PDL BioPharma Inc | 2005-05-05 | 7,555 | 2.47 | 18,661 |
| TTPH | Tetraphase Pharmaceuticals Inc | 2017-11-29 | 1,944 | 2.20 | 4,277 |
Holding Weightings of L Patrick Gage
L Patrick Gage Form 4 Trading Tracker
According to the SEC Form 4 filings, L Patrick Gage has made a total of 5 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Cytokinetics Inc is the sale of 26,468 shares on November 8, 2021, which brought L Patrick Gage around $1 Million.
According to the SEC Form 4 filings, L Patrick Gage has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the acquisition of 5,555 shares on May 5, 2005, which cost L Patrick Gage around $100,268.
According to the SEC Form 4 filings, L Patrick Gage has made a total of 0 transactions in Tetraphase Pharmaceuticals Inc (TTPH) over the past 5 years. The most-recent trade in Tetraphase Pharmaceuticals Inc is the acquisition of 194 shares on November 29, 2017, which cost L Patrick Gage around $25,026.
Insider Trading History of L Patrick Gage
- 1
L Patrick Gage Trading Performance
GuruFocus tracks the stock performance after each of L Patrick Gage's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by L Patrick Gage is 22.58%. GuruFocus also compares L Patrick Gage's trading performance to market benchmark return within the same time period. The performance of stocks bought by L Patrick Gage within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how L Patrick Gage's insider trading performs compared to the benchmark.
Performance of L Patrick Gage
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.23 | | | | | |
| Relative Return to S&P 500(%) | 6.25 | | | | | |
L Patrick Gage Ownership Network
Ownership Network List of L Patrick Gage
Ownership Network Relation of L Patrick Gage
L Patrick Gage Owned Company Details
What does Tetraphase Pharmaceuticals Inc do?
Who are the key executives at Tetraphase Pharmaceuticals Inc?
L Patrick Gage is the director of Tetraphase Pharmaceuticals Inc. Other key executives at Tetraphase Pharmaceuticals Inc include director & See Remarks Larry G. Edwards , director & 10 percent owner Steven Boyd , and director & 10 percent owner Armistice Capital Master Fund Ltd. .
Tetraphase Pharmaceuticals Inc (TTPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tetraphase Pharmaceuticals Inc (TTPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tetraphase Pharmaceuticals Inc Insider Transactions
L Patrick Gage Mailing Address
Above is the net worth, insider trading, and ownership report for L Patrick Gage. You might contact L Patrick Gage via mailing address: C/o Neose Technologies, 102 Witmer Rd, Horsham Pa 19044.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
